$WINV
WinVest Acquisition Corp Stock $winv

$winv Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-K Financial Statement

#000149315224014685 Filed on April 15, 2024

Income Statement

Concept	2024 Q2	2023 Q4	2023
Revenue	$0.00	$240.0K	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$553.2K	$190.0K	$1.765M
YoY Change	-14.88%	-64.74%	33.5%
Operating Profit	-$553.2K		-$1.765M
YoY Change	-14.88%		33.5%
Interest Expense	$142.0K	$142.9K	$749.1K
YoY Change	-38.28%	-80.07%	-46.84%
% of Operating Profit
Other Income/Expense, Net	$142.0K		$749.1K
YoY Change	-38.1%		-46.84%
Pretax Income	-$411.2K	-$144.9K	-$1.016M
YoY Change	-2.21%	-181.49%	-1262.45%
Income Tax	$29.00K	$36.00K	$132.0K
% Of Pretax Income
Net Earnings	-$440.2K	-$180.9K	-$1.148M
YoY Change	-3.99%	1794.55%	406.38%
Net Earnings / Revenue		-75.39%
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.12	-$0.04	-$0.26
COMMON SHARES
Basic Shares Outstanding	4.018M shares	4.140M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q2	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$480.00	$37.95K	$37.95K
YoY Change		-57.0%	-57.0%
Cash & Equivalents	$477.00	$37.95K
Short-Term Investments
Other Short-Term Assets	$169.7K	$133.1K	$133.1K
YoY Change	-15.15%	-52.08%	-52.08%
Inventory
Prepaid Expenses	$169.7K	$133.1K
Receivables
Other Receivables
Total Short-Term Assets	$170.2K	$270.9K	$270.9K
YoY Change	-25.21%	-25.99%	-25.99%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$5.630M	$12.45M	$12.45M
YoY Change	-58.91%	-36.37%	-36.37%
Other Assets
YoY Change
Total Long-Term Assets	$5.630M	$12.45M	$12.45M
YoY Change	-58.81%	-36.37%	-36.37%
TOTAL ASSETS
Total Short-Term Assets	$170.2K	$270.9K	$270.9K
Total Long-Term Assets	$5.630M	$12.45M	$12.45M
Total Assets	$5.800M	$12.72M	$12.72M
YoY Change	-58.26%	-36.18%	-36.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.496M	$1.217M	$1.217M
YoY Change	24.7%	148.43%	148.43%
Accrued Expenses	$154.1K	$80.44K	$80.44K
YoY Change	54.12%
Deferred Revenue
YoY Change
Short-Term Debt	$2.279M	$1.502M	$1.502M
YoY Change	153.19%	1101.2%	1101.2%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.051M	$2.988M	$2.988M
YoY Change	59.57%	221.67%	221.67%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$4.025M	$4.025M	$4.025M
YoY Change	0.63%	0.0%	0.0%
Total Long-Term Liabilities	$4.025M	$4.025M	$4.025M
YoY Change	0.63%	0.0%	0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.051M	$2.988M	$2.988M
Total Long-Term Liabilities	$4.025M	$4.025M	$4.025M
Total Liabilities	$8.076M	$7.013M	$7.013M
YoY Change	23.04%	41.56%	41.56%
SHAREHOLDERS EQUITY
Retained Earnings	-$7.906M	-$6.742M
YoY Change	24.77%	46.95%
Common Stock	$288.00	$288.00
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$7.906M	-$6.742M	$5.711M
YoY Change
Total Liabilities & Shareholders Equity	$5.800M	$12.72M	$12.72M
YoY Change	-58.26%	-36.18%	-36.18%

Cashflow Statement

Concept	2024 Q2	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$440.2K	-$180.9K	-$1.148M
YoY Change	-3.99%	1794.55%	406.38%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$449.8K	-$712.5K	-$1.256M
YoY Change	104.47%	406.95%	135.05%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$7.227M	$1.727M	$7.873M
YoY Change	10.0%	-98.24%	-91.97%
Cash From Investing Activities	$7.227M	$1.727M	$7.873M
YoY Change	10.0%	-98.24%	-91.97%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-6.827M	-977.0K	-$6.668M
YoY Change	6.51%	-99.0%	-93.19%
NET CHANGE
Cash From Operating Activities	-449.8K	-712.5K	-$1.256M
Cash From Investing Activities	7.227M	1.727M	$7.873M
Cash From Financing Activities	-6.827M	-977.0K	-$6.668M
Net Change In Cash	-49.64K	37.07K	-$50.30K
YoY Change	-17.27%	-128.96%	-88.01%
FREE CASH FLOW
Cash From Operating Activities	-$449.8K	-$712.5K	-$1.256M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	WINV	Tax Receivable Current TaxReceivableCurrent		usd
CY2022Q4	WINV	Excise Tax Payable Current ExciseTaxPayableCurrent		usd
CY2022Q4	WINV	Promissory Note Related Party PromissoryNoteRelatedParty		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2022	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense		usd
CY2022	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable		usd
CY2022	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt		usd
CY2023	us-gaap	Payments Of Distributions To Affiliates PaymentsOfDistributionsToAffiliates		usd
CY2022	WINV	Excise Tax Payable ExciseTaxPayable		usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards		usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards		usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	true
CY2023Q2	dei	Entity Public Float EntityPublicFloat	13603362	usd
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	4018123	shares
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023	dei	Auditor Firm AuditorFirmId	688
CY2023	dei	Auditor Name AuditorName	Marcum
CY2023	dei	Auditor Location AuditorLocation	Marlton, New Jersey
CY2023Q4	us-gaap	Cash Cash	37946	usd
CY2022Q4	us-gaap	Cash Cash	88247	usd
CY2023Q4	WINV	Tax Receivable Current TaxReceivableCurrent	99814	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	133117	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	277776	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	270877	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	366023	usd
CY2023Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	12453412	usd
CY2022Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	19571562	usd
CY2023Q4	us-gaap	Assets Assets	12724289	usd
CY2022Q4	us-gaap	Assets Assets	19937585	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	991998	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	382872	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	189000	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	314000	usd
CY2023Q4	WINV	Excise Tax Payable Current ExciseTaxPayableCurrent	80443	usd
CY2023Q4	WINV	Extension Note Related Party ExtensionNoteRelatedParty	1195000	usd
CY2022Q4	WINV	Extension Note Related Party ExtensionNoteRelatedParty	125000	usd
CY2023Q4	WINV	Promissory Note Related Party PromissoryNoteRelatedParty	306500	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2987941	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	928872	usd
CY2023Q4	WINV	Deferred Underwriting Commissions DeferredUnderwritingCommissions	4025000	usd
CY2022Q4	WINV	Deferred Underwriting Commissions DeferredUnderwritingCommissions	4025000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	7012941	usd
CY2022Q4	us-gaap	Liabilities Liabilities	4953872	usd
CY2023Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	1143123	shares
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	1893113	shares
CY2023Q4	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.89
CY2022Q4	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.34
CY2022Q4	us-gaap	Redeemable Noncontrolling Interest Equity Common Carrying Amount RedeemableNoncontrollingInterestEquityCommonCarryingAmount	19571562	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2875000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2875000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2875000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2875000	shares
CY2023Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	1143123	shares
CY2022Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	1893113	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	288	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	288	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6742352	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-4588137	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-6742064	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-4587849	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	12724289	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	19937585	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	1764719	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	1321875	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-1764719	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-1321875	usd
CY2023	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	756539	usd
CY2022	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	1409243	usd
CY2023	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	7428	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1015608	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	314000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-2938941	usd
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	1422276	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-226632	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-4587849	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-4587849	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-4587849	usd
CY2023	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	926164	usd
CY2023	WINV	Stock Issued During Period Value Excise Tax Payable StockIssuedDuringPeriodValueExciseTaxPayable	-80443	usd
CY2022Q4	WINV	Extension Note Related Party ExtensionNoteRelatedParty	125000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-1147608	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-6742064	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-6742064	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-226632	usd
CY2023	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	755104	usd
CY2022	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	1409243	usd
CY2023	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	99814	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-144659	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-392521	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	609126	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	288112	usd
CY2023	us-gaap	Increase Decrease In Property And Other Taxes Payable IncreaseDecreaseInPropertyAndOtherTaxesPayable	-125000	usd
CY2022	us-gaap	Increase Decrease In Property And Other Taxes Payable IncreaseDecreaseInPropertyAndOtherTaxesPayable	314000	usd
CY2023	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	118000	usd
CY2022	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	107000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1255741	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-534242	usd
CY2023	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	1070000	usd
CY2022	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	125000	usd
CY2023	WINV	Proceeds From Withdrawal Of Interest From Trust Account To Pay Taxes ProceedsFromWithdrawalOfInterestFromTrustAccountToPayTaxes	898940	usd
CY2022	WINV	Proceeds From Withdrawal Of Interest From Trust Account To Pay Taxes ProceedsFromWithdrawalOfInterestFromTrustAccountToPayTaxes	114583	usd
CY2023	WINV	Cash Withdrawn From Trust Account In Connection With Redemption CashWithdrawnFromTrustAccountInConnectionWithRedemption	8044313	usd
CY2022	WINV	Cash Withdrawn From Trust Account In Connection With Redemption CashWithdrawnFromTrustAccountInConnectionWithRedemption	98000714	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	7873253	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	97990297	usd
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	306500	usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	125000	usd
CY2023	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	1070000	usd
CY2023	WINV	Redemption Of Common Stock RedemptionOfCommonStock	8044313	usd
CY2022	WINV	Redemption Of Common Stock RedemptionOfCommonStock	98000714	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-6667813	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-97875714	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-50301	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-419659	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	88247	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	507906	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	37946	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	88247	usd
CY2023	WINV	Accretion Of Common Stock Subject To Redemption AccretionOfCommonStockSubjectToRedemption	926164	usd
CY2022	WINV	Accretion Of Common Stock Subject To Redemption AccretionOfCommonStockSubjectToRedemption	1422276	usd
CY2022	us-gaap	Payments Of Distributions To Affiliates PaymentsOfDistributionsToAffiliates	125000	usd
CY2023	WINV	Excise Tax Payable ExciseTaxPayable	80443	usd
CY2021Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	10000000	shares
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.50
CY2021Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10.00
CY2021Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	100000000	usd
CY2023	us-gaap	Debt Instrument Redemption Price Percentage DebtInstrumentRedemptionPricePercentage	1	pure
CY2023	WINV	Investment Of Cash In Trust Account InvestmentOfCashInTrustAccount	125000	usd
CY2023Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment	5000001	usd
CY2023Q4	WINV	Extension Note Related Party ExtensionNoteRelatedParty	1195000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	100000	usd
CY2023	WINV	Percentage Of Deferred Underwriting Discounts And Commissions Payable To Underwriters PercentageOfDeferredUnderwritingDiscountsAndCommissionsPayableToUnderwriters	0.035	pure
CY2022Q3	WINV	Effective Tax Description EffectiveTaxDescription	a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase.
CY2023Q2	WINV	Redemption Of Common Stock RedemptionOfCommonStock	6721795	usd
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	80443	usd
CY2023Q4	WINV	Excise Tax Liability Percentage ExciseTaxLiabilityPercentage	0.01	pure
CY2023Q4	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	349089	usd
CY2023Q4	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	240000	usd
CY2023Q4	us-gaap	Operating Expenses OperatingExpenses	190000	usd
CY2023Q4	us-gaap	Cash Cash	37946	usd
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q4	WINV	Deferred Underwriting Commissions DeferredUnderwritingCommissions	4025000	usd
CY2023	us-gaap	Professional Fees ProfessionalFees	10000	usd
CY2022Q3	WINV	Percentage Of Aggregate Sales Price Of Securities Sold PercentageOfAggregateSalesPriceOfSecuritiesSold	0.05	pure
CY2023Q4	WINV	Working Capital WorkingCapital	2717064	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-1147608	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	1764719	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_845_eus-gaap--UseOfEstimates_zT1Bu0zKEVP7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_862_zoWyzMVJznCf">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of audited condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2021Q3	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	116150000	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84D_eus-gaap--ConcentrationRiskCreditRisk_z1LOKR66fqWg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86F_z2QESnC3G3I5">Concentration of Credit Risk</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in financial institutions, which, at times, may exceed the Federal Depository Insurance Coverage of $<span id="xdx_902_eus-gaap--CashFDICInsuredAmount_iI_c20231231_zZv7BXaJPDj8" title="Cash, FDIC insured amount">250,000</span>. As of December 31, 2023, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	12453412	usd
CY2022Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	19571562	usd
CY2023	WINV	Redemption Description RedemptionDescription	Subsequent to calculating the total loss allocable to both sets of shares, the Company split the amount to be allocated using a ratio of 0% for the redeemable Public Shares and 100% for the non-redeemable shares, reflective of the respective participation rights, for the year ended December 31, 2023.
CY2023	WINV	Change In Value Of Common Stock Subject To Possible Redemption Shares ChangeInValueOfCommonStockSubjectToPossibleRedemptionShares	11966667	shares
CY2021Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.50
CY2023Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	2923969	usd
CY2023	us-gaap	Other Underwriting Expense OtherUnderwritingExpense	2400000	usd
CY2023Q4	WINV	Deferred Underwriting Commissions DeferredUnderwritingCommissions	4025000	usd
CY2022Q4	WINV	Deferred Underwriting Commissions DeferredUnderwritingCommissions	4025000	usd
CY2021Q4	us-gaap	Redeemable Noncontrolling Interest Equity Common Carrying Amount RedeemableNoncontrollingInterestEquityCommonCarryingAmount	116150000	usd
CY2022	WINV	Temporary Equity Remeasurement Value Adjustment Subject To Possible Redemption TemporaryEquityRemeasurementValueAdjustmentSubjectToPossibleRedemption	1422276	usd
CY2022	WINV	Redemption Of Common Stock RedemptionOfCommonStock	98000714	usd
CY2022Q4	us-gaap	Redeemable Noncontrolling Interest Equity Common Carrying Amount RedeemableNoncontrollingInterestEquityCommonCarryingAmount	19571562	usd
CY2023	WINV	Deposits To Trust Account DepositsToTrustAccount	1070000	usd
CY2023	WINV	Stock Issued During Period Value Taxes Withdrawn From Trust Account StockIssuedDuringPeriodValueTaxesWithdrawnFromTrustAccount	898940	usd
CY2023	WINV	Redemption Of Common Stock RedemptionOfCommonStock	8044313	usd
CY2023Q4	us-gaap	Redeemable Noncontrolling Interest Equity Common Carrying Amount RedeemableNoncontrollingInterestEquityCommonCarryingAmount	12453412	usd
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	11.50
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	131500	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	241000	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	500	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	73000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	132000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	314000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-257000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-222850	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-67100	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-257000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-289950	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	257000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	289950	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	132000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	314000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.000	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.063	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.063	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.0000	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.017	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	3.381	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.130	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	3.591	pure
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense DeferredTaxAssetsTaxDeferredExpense	633000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense DeferredTaxAssetsTaxDeferredExpense	376000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	633000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	376000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	633000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	376000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	633000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	376000	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	257000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	289950	usd

Files In Submission

Name	View Source	Status
0001493152-24-014685-index-headers.html	Edgar Link	pending
0001493152-24-014685-index.html	Edgar Link	pending
0001493152-24-014685.txt	Edgar Link	pending
0001493152-24-014685-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex97-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
winv-20231231.xsd	Edgar Link	pending
winv-20231231_cal.xml	Edgar Link	unprocessable
winv-20231231_def.xml	Edgar Link	unprocessable
winv-20231231_pre.xml	Edgar Link	unprocessable
winv-20231231_lab.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$WINV
WinVest Acquisition Corp Stock $winv

2024 Q2 Form 10-K Financial Statement

#000149315224014685 Filed on April 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$WINV WinVest Acquisition Corp Stock $winv

2024 Q2 Form 10-K Financial Statement

#000149315224014685 Filed on April 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$WINV
WinVest Acquisition Corp Stock $winv